BMY:NYE-Bristol-Myers Squibb Company (USD)

EQUITY | Drug Manufacturers - General | New York Stock Exchange

Last Closing

USD 41.53

Change

+0.02 (+0.05)%

Market Cap

USD 93.95B

Volume

0.02B

Analyst Target

USD 73.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Bristol-Myers Squibb Co is a biopharmaceutical company. It discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-28 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
LLY Eli Lilly and Company

N/A

USD 832.38B
JNJ Johnson & Johnson

N/A

USD 391.85B
ABBV AbbVie Inc

N/A

USD 344.07B
PFE Pfizer Inc

N/A

USD 166.09B
OGN Organon & Co

N/A

USD 4.94B
GSK GlaxoSmithKline PLC ADR

N/A

N/A
MRK Merck & Company Inc

N/A

N/A
NVS Novartis AG ADR

N/A

N/A

ETFs Containing BMY

FHI-B:CA CI Health Care Giants Cov.. 5.55 % 0.00 %

N/A

CAD 0.05B
PPH VanEck Pharmaceutical ETF 4.73 % 0.36 %

N/A

USD 0.72B
KNGU:CA Brompton U.S. Cash Flow K.. 4.73 % 0.00 %

N/A

CAD 4.99M
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.55 % 0.00 %

N/A

N/A
XGES:LSE Xtrackers MSCI Genomic He.. 4.49 % 0.00 %

N/A

N/A
MEDX Horizon Kinetics Medical .. 4.15 % 0.00 %

N/A

N/A
SCHD Schwab U.S. Dividend Equi.. 4.00 % 0.07 %

N/A

USD 61.23B
LSAT Two Roads Shared Trust - .. 3.72 % 0.00 %

N/A

USD 0.13B
USMV:LSE Ossiam US Minimum Varianc.. 3.00 % 0.00 %

N/A

USD 0.01B
MVUS:PA 3.00 % 0.00 %

N/A

N/A
SPMV:PA 3.00 % 0.00 %

N/A

N/A
OSX2:XETRA Ossiam US Minimum Varianc.. 3.00 % 0.00 %

N/A

USD 0.12B
CDNA:CA CI Bio-Revolution Index E.. 2.95 % 0.00 %

N/A

CAD 6.10M
XDGI:XETRA Xtrackers MSCI Global SDG.. 2.71 % 0.00 %

N/A

USD 0.02B
HEAL:CA 2.66 % 0.00 %

N/A

N/A
WTD9:F WisdomTree US Equity Inco.. 2.63 % 0.00 %

N/A

USD 0.06B
WTDY:F WisdomTree Issuer ICAV - .. 2.63 % 0.00 %

N/A

USD 1.58M
WTEU:F WisdomTree US Equity Inco.. 2.63 % 0.00 %

N/A

USD 0.11B
WTD9:XETRA WisdomTree Issuer ICAV - .. 2.63 % 0.00 %

N/A

USD 0.05B
WTDY:XETRA WisdomTree Issuer ICAV - .. 2.63 % 0.00 %

N/A

USD 0.85M
WTEU:XETRA WisdomTree US Equity Inco.. 2.63 % 0.00 %

N/A

USD 0.11B
HDLV:PA Invesco S&P 500 High Divi.. 2.56 % 0.00 %

N/A

USD 0.55B
HDLV:XETRA Invesco S&P 500 High Divi.. 2.56 % 0.00 %

N/A

USD 0.31B
HDCH:SW Invesco S&P 500 High Divi.. 2.56 % 0.00 %

N/A

USD 3.54M
ZYUS:AU ANZ S&P 500 High Yield Lo.. 2.56 % 0.00 %

N/A

USD 0.07B
SPHD Invesco S&P 500® High Di.. 2.53 % 0.30 %

N/A

USD 3.52B
VSDA VictoryShares Dividend Ac.. 2.46 % 0.35 %

N/A

USD 0.26B
VDIV:F VanEck Vectors ETFs N.V... 2.43 % 0.00 %

N/A

USD 0.64B
VDIV:XETRA VanEck Morningstar Develo.. 2.43 % 0.00 %

N/A

USD 0.64B
TDIV:SW VanEck Morningstar Develo.. 2.43 % 0.00 %

N/A

USD 0.97B
DHS:SW WisdomTree US Equity Inco.. 2.39 % 0.00 %

N/A

N/A
DHSA:SW WisdomTree US Equity Inco.. 2.39 % 0.00 %

N/A

N/A
NXTV 2.35 % 0.00 %

N/A

N/A
TDGB:LSE VanEck Morningstar Develo.. 2.35 % 0.00 %

N/A

USD 0.97B
TDOC:CA TD Global Healthcare Lead.. 2.24 % 0.00 %

N/A

CAD 0.09B
LRND IQ U.S. Large Cap R&D Lea.. 2.21 % 0.00 %

N/A

USD 7.50M
PUD.B:CA 1.82 % 0.66 %

N/A

N/A
RSPH Invesco S&P 500® Equal.. 1.80 % 0.00 %

N/A

USD 1.02B
UVDV 1.72 % 0.00 %

N/A

N/A
2B78:XETRA iShares Healthcare Innova.. 1.67 % 0.00 %

N/A

USD 1.14B
HEAL:SW iShares Healthcare Innova.. 1.65 % 0.00 %

N/A

N/A
ZLU-U:CA BMO Low Volatility US Equ.. 1.65 % 0.00 %

N/A

N/A
ZLU:CA BMO Low Volatility US Equ.. 1.65 % 0.33 %

N/A

CAD 1.78B
2B78:F iShares Healthcare Innova.. 1.60 % 0.00 %

N/A

N/A
EDGE-U:CA Evolve Innovation Index F.. 1.52 % 0.00 %

N/A

N/A
UC82:LSE UBS(Lux)Fund Solutions .. 1.35 % 0.00 %

N/A

USD 0.07B
UC86:LSE UBS(Lux)Fund Solutions .. 1.35 % 0.00 %

N/A

USD 0.28B
SPXB 1.32 % 0.15 %

N/A

N/A
UC98:LSE UBS(Lux)Fund Solutions .. 0.74 % 0.00 %

N/A

USD 0.19B
BSUS:LSE UBS(Lux)Fund Solutions .. 0.72 % 0.00 %

N/A

N/A
UC97:LSE UBS(Lux)Fund Solutions .. 0.72 % 0.00 %

N/A

USD 0.19B
UET0:F UBS (Lux) Fund Solutions .. 0.65 % 0.00 %

N/A

N/A
UET0:XETRA UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

USD 0.21B
CBSUST:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

N/A
CBSUS:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

N/A
CBSUSE:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

N/A
CBSUSH:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

N/A
QUIG:CA Mackenzie US Investment G.. 0.62 % 0.28 %

N/A

CAD 0.55B
UC76:LSE UBS Barclays US Liquid Co.. 0.53 % 0.00 %

N/A

USD 0.09B
UC85:LSE UBS Barclays US Liquid Co.. 0.53 % 0.00 %

N/A

USD 0.07B
DHS WisdomTree U.S. High Divi.. 0.00 % 0.38 %

N/A

N/A
GBF iShares Government/Credit.. 0.00 % 0.20 %

N/A

N/A
IHE iShares U.S. Pharmaceutic.. 0.00 % 0.42 %

N/A

N/A
JHMH 0.00 % 0.46 %

N/A

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

N/A

N/A
PILL Direxion Daily Pharmaceut.. 0.00 % 0.98 %

N/A

N/A
QLTA iShares Aaa - A Rated Cor.. 0.00 % 0.15 %

N/A

USD 1.42B
NUBD Nuveen ESG U.S. Aggregate.. 0.00 % 0.20 %

N/A

USD 0.41B
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

N/A

USD 0.02B
HONR 0.00 % 0.65 %

N/A

N/A
EDGE:CA Evolve Innovation Index F.. 0.00 % 0.60 %

N/A

CAD 0.04B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

N/A

CAD 0.07B
HUL-U:CA 0.00 % 0.00 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

N/A

N/A
SICK 0.00 % 0.95 %

N/A

N/A
UXM.B:CA 0.00 % 0.67 %

N/A

N/A
HUL:CA 0.00 % 2.20 %

N/A

N/A
BVAL 0.00 % 0.65 %

N/A

N/A
DHS:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSA:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSD:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSG:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSP:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
LUMV:LSE Ossiam US Minimum Varianc.. 0.00 % 0.00 %

N/A

N/A
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

N/A

USD 0.09B
OSX2:F Ossiam Lux - Ossiam US Mi.. 0.00 % 0.00 %

N/A

N/A
VMUS:XETRA 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
HART IQ Healthy Hearts ETF 0.00 % 0.00 %

N/A

USD 9.09M

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -19.06% 9% A- 10% F
Dividend Return 2.34% 73% C 61% D-
Total Return -16.72% 9% A- 10% F
Trailing 12 Months  
Capital Gain -35.06% 9% A- 7% C-
Dividend Return 3.66% 55% F 53% F
Total Return -31.40% 9% A- 8% B-
Trailing 5 Years  
Capital Gain -8.42% 20% F 38% F
Dividend Return 22.54% 75% C 78% C+
Total Return 14.11% 30% F 45% F
Average Annual (5 Year Horizon)  
Capital Gain 0.28% 45% F 43% F
Dividend Return 3.49% 27% F 46% F
Total Return 3.21% 55% F 63% D
Risk Return Profile  
Volatility (Standard Deviation) 19.71% 45% F 52% F
Risk Adjusted Return 17.70% 27% F 42% F
Market Capitalization 93.95B 45% F 97% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Drug Manufacturers - General) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 12.66 91% 65%
Price/Book Ratio 5.15 45% 17%
Price / Cash Flow Ratio 6.17 82% 54%
Price/Free Cash Flow Ratio 24.95 27% 9%
Management Effectiveness  
Return on Equity -25.33% 10% 12%
Return on Invested Capital 24.13% 91% 91%
Return on Assets 5.39% 18% 75%
Debt to Equity Ratio 124.54% 33% 27%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.